CorMedix Inc.
CRMD$910M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaPARSIPPANY
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Aug 6, 2026
6wMarket Overview
Stock performance and key metrics
CRMD News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
(taurolidine and heparin) catheter lock solution
Central Line Associated Blood Stream Infections (CLABSI)
Neutrolin
Kidney Failure, Chronic
CRMD-001-Deferiprone
Contrast-Induced Acute Kidney Injury
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
(taurolidine and heparin) catheter lock solution | Phase 3 | Central Line Associated Blood Stream Infections (CLABSI) | - | - |
Neutrolin | Phase 3 | Kidney Failure, Chronic | - | - |
CRMD-001-Deferiprone | Phase 2 | Contrast-Induced Acute Kidney Injury | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply